New appointments in the pharmaceutical industry
Enhanc3D Genomics has announced the appointment of Hazel Jones as chief operating officer.
Oxolife has announced that it has appointed globally renowned fertility experts to its scientific advisory board.
IO Biotech has announced the appointment of Helen Collins MD to its board of directors.
NanoSyrinx has announced the appointment of Anthony Johnson MD to its board as non-executive director.
Closed Loop Medicine has announced the appointment of Konstantinos Vlassis as chief technology officer.
CEO and president of FUJIFILM Diosynth Biotechnologies Lars Petersen has appointed Maja Pedersen as chief quality officer, where she will serve as a member of the executive leadership team.
Invisius Limited has announced that it has appointed Professor Bernard Canaud to its clinical advisory board.
Pheon Therapeutics has announced hat it has appointed Arvin Yang MD PhD as chief medical officer.
Hansa Biopharma has announced the appointment of Dr Hitto Kaufmann as its new chief scientific officer effective 1 December 2023.
Clinical stage biotech company Destiny Pharma has announced the appointment of Chris Tovey as chief executive officer.
Bristol Myers Squibb announces appointment of Dr Monica Shaw
CN Bio has announced the appointment of Dr Tomasz Kostrzewski as chief scientific officer